本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Janux Therapeutics, Inc.

28.72
-0.5600-1.91%
成交量:92.68萬
成交額:2,688.85萬
市值:17.27億
市盈率:-17.09
高:29.94
開:28.95
低:28.34
收:29.28
52周最高:71.71
52周最低:21.73
股本:6,014.78萬
流通股本:4,496.69萬
量比:1.13
換手率:2.06%
股息:- -
股息率:- -
每股收益(TTM):-1.6802
每股收益(LYR):-1.2836
淨資產收益率:-12.48%
總資產收益率:-10.49%
市淨率:1.77
市盈率(LYR):-22.38

資料載入中...

2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/19

重要事件披露

Form 8-K - Current report
2023/07/17

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/07/17

重要事件披露

Form 8-K - Current report
2023/07/10

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/24

重要事件披露

Form 8-K - Current report
2023/06/21

重要事件披露

Form 8-K - Current report
2023/05/31

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/09

重要事件披露

8-K - Current report